| dc.contributor.author | MacLeod, Angus D. | |
| dc.contributor.author | Goddard, Hannah | |
| dc.contributor.author | Counsell, Carl E. | |
| dc.date.accessioned | 2016-05-26T10:40:07Z | |
| dc.date.available | 2016-05-26T10:40:07Z | |
| dc.date.issued | 2016-07 | |
| dc.identifier.citation | MacLeod , A D , Goddard , H & Counsell , C E 2016 , ' Co-morbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosis ' , Parkinsonism & Related Disorders , vol. 28 , pp. 124-129 . https://doi.org/10.1016/j.parkreldis.2016.05.013 | en |
| dc.identifier.issn | 1353-8020 | |
| dc.identifier.other | PURE: 66682600 | |
| dc.identifier.other | PURE UUID: 750801a2-adcd-4ea4-acbb-07f33e2f59a1 | |
| dc.identifier.other | Scopus: 84974829824 | |
| dc.identifier.uri | http://hdl.handle.net/2164/6015 | |
| dc.description | Financial support This study was funded by Parkinson’s UK, the Scottish Chief Scientist Office, NHS Grampian endowments, the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, and SPRING. The funders had no involvement in the study. Acknowledgements We acknowledge funding for the PINE study from Parkinson’s UK (G-0502, G-0914, G-1302), the Scottish Chief Scientist Office(CAF/12/05), the BMA Doris Hillier award, RS Macdonald Trust, the BUPA Foundation, NHS Grampian endowments and SPRING. We thank the patients and controls for their participation and the research staff who collected data and supported the study database. | en |
| dc.format.extent | 6 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Parkinsonism & Related Disorders | en |
| dc.rights | © 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). | en |
| dc.subject | Parkinson’s disease | en |
| dc.subject | co-morbidity | en |
| dc.subject | Charlson | en |
| dc.subject | mortality | en |
| dc.subject | dependency | en |
| dc.subject | RC Internal medicine | en |
| dc.subject | Parkinson's UK | en |
| dc.subject | G-0502 | en |
| dc.subject | G-0914 | en |
| dc.subject | G-1302 | en |
| dc.subject | Chief Scientist Office (CSO) | en |
| dc.subject | CAF/12/05 | en |
| dc.subject.lcc | RC | en |
| dc.title | Co-morbidity burden in Parkinson’s disease : Comparison with controls and its influence on prognosis | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Chronic Disease Research Group | en |
| dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
| dc.contributor.institution | University of Aberdeen.Grampian Data Safe Haven (DaSH) | en |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.description.status | Peer reviewed | en |
| dc.description.version | Postprint | en |
| dc.description.version | Postprint | en |
| dc.description.version | Publisher PDF | en |
| dc.identifier.doi | https://doi.org/10.1016/j.parkreldis.2016.05.013 | |
| dc.identifier.vol | 28 | en |
